|
MAPKAPK5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.004000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.715400E-03 |
| Normal-vs-Stage2 |
2.323900E-02 |
| Normal-vs-Stage3 |
3.482300E-03 |
| Normal-vs-Stage4 |
1.333600E-02 |
| Stage1-vs-Stage2 |
5.886600E-01 |
| Stage1-vs-Stage3 |
4.995200E-01 |
| Stage1-vs-Stage4 |
5.931400E-01 |
| Stage2-vs-Stage3 |
9.553000E-01 |
| Stage2-vs-Stage4 |
9.816400E-01 |
| Stage3-vs-Stage4 |
9.752800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.175400E-03 |
| Normal-vs-AfricanAmerican |
8.605800E-01 |
| Normal-vs-Asian |
1.294030E-02 |
| Caucasian-vs-AfricanAmerican |
1.894010E-01 |
| Caucasian-vs-Asian |
5.976800E-01 |
| AfricanAmerican-vs-Asian |
9.353600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.098900E-03 |
| Normal-vs-Female |
3.957300E-03 |
| Male-vs-Female |
6.534600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.775950E-02 |
| Normal-vs-Age(41-60Yrs) |
1.080270E-02 |
| Normal-vs-Age(61-80Yrs) |
1.523930E-03 |
| Normal-vs-Age(81-100Yrs) |
9.873600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.632200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.483600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.026200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.915000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.120800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.520800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.823800E-01 |
| Classical-VS-Follicular |
2.335200E-03 |
| Classical-VS-Other |
3.017200E-01 |
| Classical-VS-Normal |
1.043430E-01 |
| Tall-VS-Follicular |
1.185660E-02 |
| Tall-VS-Other |
2.802200E-01 |
| Tall-VS-Normal |
4.175800E-01 |
| Follicular-VS-Other |
8.024400E-01 |
| Follicular-VS-Normal |
1.624170E-04 |
| Other-VS-Normal |
2.531400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.184500E-04 |
| Normal-vs-N1 |
1.524470E-03 |
| N0-vs-N1 |
6.184800E-01 |
|
|
